The Exec: How Penn Medicine’s CFO Is Reshaping Capital Strategy, Growth, and Financial Discipline

New CFO Michele Wingate is redefining how Penn Medicine Medical Group approaches capital allocation, partnerships, and workforce strategy all while balancing mission-driven investment with long-term financial resilience.

As healthcare margins tighten and capital becomes more constrained, CFOs are being forced to rethink how growth, investment, and operational discipline intersect.

At Penn Medicine Medical Group, newly appointed CFO Michele Wingate is approaching that challenge with a deliberate shift toward long-range planning, collaborative decision-making, and disciplined capital deployment.

Since stepping into the role in June 2025, Wingate has focused on building a financial strategy that integrates mission priorities with measurable returns while balancing immediate operational needs with investments that support long-term system growth and sustainability.

Capital Allocation Strategy

Wingate describes capital allocation as a highly collaborative, multifactor process driven by strategy, patient care needs, financial returns, and long-term planning. During budgeting, requests often exceed available resources, making prioritization critical—grouping investments across areas like ambulatory care, hospitals, and infrastructure, while recognizing that essential but less visible needs persist.

“Patient care is going to trump some of these other things,” she says.

She emphasizes disciplined financial evaluation, while also acknowledging exceptions for necessary investments (like facility repairs) that may not generate direct returns. Ultimately, decisions are multifactorial, balancing growth priorities, system strategy, and multi-year impact rather than “just one year in a vacuum,” she says.

“We run ROIs on everything,” she says.

She also highlights supply chain alignment as an ongoing challenge, stressing the importance of standardization and stakeholder buy-in to unlock savings. Success depends on demonstrating value to clinicians.

“Without that [demonstration], they're just going to say, ‘no, I've always used this type of machine.’”

Partnerships as a Capital-Efficient Growth Strategy

Wingate describes evaluating strategic growth opportunities as a careful balance between mission alignment and financial discipline. She emphasizes thorough vetting of potential partners.

“You really have to do your due diligence of who you're going to partner with and really make sure that you're not talking past each other in terms of what you're really trying to accomplish,” she says. 

Partnerships are used to enter markets outside the system’s core expertise without overextending resources.

“We can't be all things to all people,” she says.

That collaboration allows Penn Medicine to leverage strengths while protecting long-term financial health.

She also highlights the importance of running new initiatives efficiently, particularly in areas like ambulatory surgery, to ensure quality care while maintaining financial sustainability. Investments that may not yield immediate returns are justified by their downstream contributions to research, teaching, and the broader mission. This all reinforces a holistic, strategic approach to growth.

Workforce Strategy and Labor Cost Discipline

Wingate frames workforce strategy as a core financial lever, particularly in managing labor cost volatility. A primary focus has been reducing reliance on agency labor and accelerating the integration of newly acquired hospitals, such as Doylestown, to standardize staffing models and improve cost structure.

At the same time, Penn Medicine is rationalizing a complex benefits structure spanning more than 80 plans, with the goal of improving consistency, competitiveness, and long-term retention.

For Wingate, workforce investment is not just about cost control, it’s about stabilizing operations and reducing variability that can impact both margin and care delivery.

“We try to find people who are there for the mission and believe in what we're doing,” she says.

Her approach acknowledges that academic systems may not always offer the highest pay, but emphasizes a broader value proposition—career development, mission alignment, and comprehensive benefits—while maintaining financial caution.

Balancing Innovation with Financial Discipline

Wingate applies a disciplined governance model to innovation, particularly in emerging areas like AI. New technologies are evaluated through structured review committees that assess clinical impact, operational efficiency, risk, and return on investment before approval.

Rather than pursuing early adoption, the organization prioritizes proven applications that can deliver measurable improvements in productivity, quality, or cost. This approach limits unnecessary capital exposure while ensuring that innovation investments align with broader financial and operational goals.

“We're probably the ones that are going to be the slowest to adapt to new technology because of the need for thorough vetting,” she says.

Financial stewardship remains central, as the organization carefully evaluates return on investment and avoids unnecessary debt.

Ultimately, the approach is to explore innovation thoughtfully while consistently maintaining strong financial health.

“Being cautious around this and not just jumping in with both feet is the right approach,” she says.

Leadership Strategy in the CFO Role

Wingate views the modern CFO role as deeply integrated with operations, requiring close alignment with clinical leadership to drive margin improvement and system performance.

Rather than operating as a traditional financial gatekeeper, she emphasizes partnership across the organization to ensure that financial decisions support both operational efficiency and patient care outcomes.

This includes maintaining visibility into frontline challenges, aligning incentives across departments, and ensuring that financial strategy is embedded in day-to-day decision-making. As health systems face increasing complexity, Wingate sees the CFO role as central to coordinating strategy across clinical, operational, and financial domains.